- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03976141
New Topographic Classification of Knee Bone Marrow Lesions (ncbe)
November 13, 2020 updated by: Pietro Randelli, MD, University of Milan
Validation of a New Topographic Classification of Bone Marrow Lesions of the Knee
the investigator are studying a new topographic classification of bone marrow lesion in the knee and validating it.
Study Overview
Study Type
Observational
Enrollment (Actual)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Milan
-
Milano, Milan, Italy, 20122
- 2) 1° Clinica Ortopedica, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
exam in 2018
Description
Inclusion Criteria:
- age over 18 with mri with lesion consent given
Exclusion Criteria:
- under mri previous surgery tumors no consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
a
|
knee mri
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The researchers will calculate the prevalence of BMLs in knee MRI and calculate the intra-observer and inter-observer reliability of the new classification proposed.
Time Frame: The lesions will be evaluated on knee MRI performed in the period between January 2017 to December 2018
|
This study proposes a topographic classification for knee BMLs consisting in 5 different types of lesions.
the classification proposed will be validated by 3 independent researchers.
|
The lesions will be evaluated on knee MRI performed in the period between January 2017 to December 2018
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 14, 2019
Primary Completion (Actual)
May 30, 2019
Study Completion (Actual)
April 30, 2020
Study Registration Dates
First Submitted
May 17, 2019
First Submitted That Met QC Criteria
June 4, 2019
First Posted (Actual)
June 5, 2019
Study Record Updates
Last Update Posted (Actual)
November 16, 2020
Last Update Submitted That Met QC Criteria
November 13, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- ncbe
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Bone Marrow Lesions
-
Zimmer BiometCompletedBone Marrow Edema | Bone Marrow LesionsGermany, Netherlands, Italy, Spain, United Kingdom
-
Nantes University HospitalTerminatedBone Demineralization Lesions in the Injured MarrowFrance
-
Nanochon, Inc.RecruitingKnee Cartilage LesionsCanada
-
Nanochon, Inc.Not yet recruitingKnee Cartilage LesionsPanama
-
Second Affiliated Hospital of Nanchang UniversityActive, not recruitingOsteo Arthritis | Osteochondral Lesions of KneeChina
-
University Hospital, Basel, SwitzerlandCompletedOsteonecrosis of the Knee | Bone Marrow Edema of the KneeSwitzerland
-
MennaTalla Saber Sabet MohamedNot yet recruiting
-
Smith & Nephew, Inc.Cartiheal (2009) LtdEnrolling by invitationKnee Injuries | Joint Surface Knee LesionsItaly, United States, Belgium, Israel, Romania, Serbia
-
Fin-Ceramica Faenza SpaNot yet recruitingEarly Osteoarthritis | Osteochondritis Dissecans (OCD) | Osteochondral Lesions of the Knee Joint
-
University of CalgaryMcCaig Institute for Bone and Joint Health - Centre for Mobility and Joint...UnknownKnee Osteoarthritis | Osteoarthritis, Knee | Musculoskeletal Disease | Bone Marrow Edema | Arthroscopy | Subchondral Bone EdemaCanada
Clinical Trials on mri
-
Cambridge University Hospitals NHS Foundation TrustRecruitingBreast CancerUnited Kingdom
-
Seoul National University Bundang HospitalBayerCompletedTraumaKorea, Republic of
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedOsteosarcoma | Ewing Sarcoma | Paget's DiseaseUnited States
-
Abbott Medical DevicesCompletedAdverse Effect of MRI on an Implanted Pacemaker Lead | Adverse Effect of MRI on an Implanted PacemakerUnited States, Netherlands, Australia, Belgium, Finland
-
Assistance Publique Hopitaux De MarseilleActive, not recruitingMultiple SclerosisFrance
-
Centre Hospitalier Universitaire de Saint EtienneLohmann & RauscherRecruitingLow Back Pain | Healthy VolunteerFrance
-
University of EdinburghCompleted
-
Assistance Publique - Hôpitaux de ParisUnknownBrain Injury, Coma | Cardiac Arrest (CA) | Traumatic Brain Injury (TBI) | Aneurysmal Subarachnoid Hemorrhages (aSAH)France
-
Sheba Medical CenterUnknown
-
Icahn School of Medicine at Mount SinaiThe Fonar CorporationRecruitingProstate Cancer | Elevated PSA | Elevated Prostate Specific AntigenUnited States